Adagio Medical Holdings down; founder, CEO Olav Bergheim steps down
** Shares of medical devices developer Adagio Medical
Holdings ADGM.O fall as much as 6.3% to $1.89 in early trade
** Co says founder and CEO Olav Bergheim is stepping down
effective Dec. 13
** Appoints Todd Usen, previously CEO of Minerva Surgical
and Activ Surgical, as new CEO
** Bergheim to serve as an advisor through Dec 12, 2025
** Including session moves, stock has fallen ~82% YTD
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
Adagio Medical rises after FDA clears expanded testing of heart device